ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pediatric Diabetes Therapeutic Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-28N17035
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Pediatric Diabetes Therapeutic Market Research Report 2024
BUY CHAPTERS

Global Pediatric Diabetes Therapeutic Market Research Report 2024

Code: QYRE-Auto-28N17035
Report
May 2024
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boehringer Ingelheim International GmbH
Eli Lilly and Company
Sanofi
Vertex Pharmaceuticals Incorporated
Novo Nordisk A S
Astrazeneca plc
MannKind Corporation
Xeris Pharmaceuticals
Amphastar Pharmaceuticals Inc

Pediatric Diabetes Therapeutic Market

Pediatric diabetes therapeutic options aim to manage blood glucose levels in children and adolescents diagnosed with diabetes mellitus. The two main types of pediatric diabetes are type 1 diabetes (T1D) and type 2 diabetes (T2D), with T1D being more common in children.
The global Pediatric Diabetes Therapeutic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pediatric Diabetes Therapeutic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pediatric Diabetes Therapeutic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pediatric Diabetes Therapeutic include Boehringer Ingelheim International GmbH, Eli Lilly and Company, Sanofi, Vertex Pharmaceuticals incorporated, Novo Nordisk A/S, AstraZeneca, MannKind Corporation, Xeris Pharmaceuticals, Amphastar Pharmaceuticals, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pediatric Diabetes Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Diabetes Therapeutic.
The Pediatric Diabetes Therapeutic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pediatric Diabetes Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Diabetes Therapeutic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pediatric Diabetes Therapeutic Market Report

Report Metric Details
Report Name Pediatric Diabetes Therapeutic Market
Segment by Type
  • Type 1
  • Type 2
Segment by Application
  • Hospitals
  • Specialty Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim International GmbH, Eli Lilly and Company, Sanofi, Vertex Pharmaceuticals incorporated, Novo Nordisk A/S, AstraZeneca, MannKind Corporation, Xeris Pharmaceuticals, Amphastar Pharmaceuticals, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pediatric Diabetes Therapeutic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pediatric Diabetes Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pediatric Diabetes Therapeutic Market report?

Ans: The main players in the Pediatric Diabetes Therapeutic Market are Boehringer Ingelheim International GmbH, Eli Lilly and Company, Sanofi, Vertex Pharmaceuticals incorporated, Novo Nordisk A/S, AstraZeneca, MannKind Corporation, Xeris Pharmaceuticals, Amphastar Pharmaceuticals, Inc.

What are the Application segmentation covered in the Pediatric Diabetes Therapeutic Market report?

Ans: The Applications covered in the Pediatric Diabetes Therapeutic Market report are Hospitals, Specialty Clinics, Others

What are the Type segmentation covered in the Pediatric Diabetes Therapeutic Market report?

Ans: The Types covered in the Pediatric Diabetes Therapeutic Market report are Type 1, Type 2

1 Pediatric Diabetes Therapeutic Market Overview
1.1 Product Definition
1.2 Pediatric Diabetes Therapeutic by Type
1.2.1 Global Pediatric Diabetes Therapeutic Market Value Comparison by Type (2024-2030)
1.2.2 Type 1
1.2.3 Type 2
1.3 Pediatric Diabetes Therapeutic by Application
1.3.1 Global Pediatric Diabetes Therapeutic Market Value by Application (2024-2030)
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Global Pediatric Diabetes Therapeutic Market Size Estimates and Forecasts
1.4.1 Global Pediatric Diabetes Therapeutic Revenue 2019-2030
1.4.2 Global Pediatric Diabetes Therapeutic Sales 2019-2030
1.4.3 Global Pediatric Diabetes Therapeutic Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pediatric Diabetes Therapeutic Market Competition by Manufacturers
2.1 Global Pediatric Diabetes Therapeutic Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pediatric Diabetes Therapeutic Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pediatric Diabetes Therapeutic Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Pediatric Diabetes Therapeutic, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pediatric Diabetes Therapeutic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pediatric Diabetes Therapeutic, Product Type & Application
2.7 Global Key Manufacturers of Pediatric Diabetes Therapeutic, Date of Enter into This Industry
2.8 Global Pediatric Diabetes Therapeutic Market Competitive Situation and Trends
2.8.1 Global Pediatric Diabetes Therapeutic Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pediatric Diabetes Therapeutic Players Market Share by Revenue
2.8.3 Global Pediatric Diabetes Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pediatric Diabetes Therapeutic Market Scenario by Region
3.1 Global Pediatric Diabetes Therapeutic Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pediatric Diabetes Therapeutic Sales by Region: 2019-2030
3.2.1 Global Pediatric Diabetes Therapeutic Sales by Region: 2019-2024
3.2.2 Global Pediatric Diabetes Therapeutic Sales by Region: 2025-2030
3.3 Global Pediatric Diabetes Therapeutic Revenue by Region: 2019-2030
3.3.1 Global Pediatric Diabetes Therapeutic Revenue by Region: 2019-2024
3.3.2 Global Pediatric Diabetes Therapeutic Revenue by Region: 2025-2030
3.4 North America Pediatric Diabetes Therapeutic Market Facts & Figures by Country
3.4.1 North America Pediatric Diabetes Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pediatric Diabetes Therapeutic Sales by Country (2019-2030)
3.4.3 North America Pediatric Diabetes Therapeutic Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pediatric Diabetes Therapeutic Market Facts & Figures by Country
3.5.1 Europe Pediatric Diabetes Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pediatric Diabetes Therapeutic Sales by Country (2019-2030)
3.5.3 Europe Pediatric Diabetes Therapeutic Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pediatric Diabetes Therapeutic Market Facts & Figures by Region
3.6.1 Asia Pacific Pediatric Diabetes Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pediatric Diabetes Therapeutic Sales by Region (2019-2030)
3.6.3 Asia Pacific Pediatric Diabetes Therapeutic Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pediatric Diabetes Therapeutic Market Facts & Figures by Country
3.7.1 Latin America Pediatric Diabetes Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pediatric Diabetes Therapeutic Sales by Country (2019-2030)
3.7.3 Latin America Pediatric Diabetes Therapeutic Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pediatric Diabetes Therapeutic Market Facts & Figures by Country
3.8.1 Middle East and Africa Pediatric Diabetes Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pediatric Diabetes Therapeutic Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pediatric Diabetes Therapeutic Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pediatric Diabetes Therapeutic Sales by Type (2019-2030)
4.1.1 Global Pediatric Diabetes Therapeutic Sales by Type (2019-2024)
4.1.2 Global Pediatric Diabetes Therapeutic Sales by Type (2025-2030)
4.1.3 Global Pediatric Diabetes Therapeutic Sales Market Share by Type (2019-2030)
4.2 Global Pediatric Diabetes Therapeutic Revenue by Type (2019-2030)
4.2.1 Global Pediatric Diabetes Therapeutic Revenue by Type (2019-2024)
4.2.2 Global Pediatric Diabetes Therapeutic Revenue by Type (2025-2030)
4.2.3 Global Pediatric Diabetes Therapeutic Revenue Market Share by Type (2019-2030)
4.3 Global Pediatric Diabetes Therapeutic Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pediatric Diabetes Therapeutic Sales by Application (2019-2030)
5.1.1 Global Pediatric Diabetes Therapeutic Sales by Application (2019-2024)
5.1.2 Global Pediatric Diabetes Therapeutic Sales by Application (2025-2030)
5.1.3 Global Pediatric Diabetes Therapeutic Sales Market Share by Application (2019-2030)
5.2 Global Pediatric Diabetes Therapeutic Revenue by Application (2019-2030)
5.2.1 Global Pediatric Diabetes Therapeutic Revenue by Application (2019-2024)
5.2.2 Global Pediatric Diabetes Therapeutic Revenue by Application (2025-2030)
5.2.3 Global Pediatric Diabetes Therapeutic Revenue Market Share by Application (2019-2030)
5.3 Global Pediatric Diabetes Therapeutic Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim International GmbH
6.1.1 Boehringer Ingelheim International GmbH Company Information
6.1.2 Boehringer Ingelheim International GmbH Description and Business Overview
6.1.3 Boehringer Ingelheim International GmbH Pediatric Diabetes Therapeutic Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim International GmbH Pediatric Diabetes Therapeutic Product Portfolio
6.1.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
6.2 Eli Lilly and Company
6.2.1 Eli Lilly and Company Company Information
6.2.2 Eli Lilly and Company Description and Business Overview
6.2.3 Eli Lilly and Company Pediatric Diabetes Therapeutic Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly and Company Pediatric Diabetes Therapeutic Product Portfolio
6.2.5 Eli Lilly and Company Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Pediatric Diabetes Therapeutic Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Pediatric Diabetes Therapeutic Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Vertex Pharmaceuticals incorporated
6.4.1 Vertex Pharmaceuticals incorporated Company Information
6.4.2 Vertex Pharmaceuticals incorporated Description and Business Overview
6.4.3 Vertex Pharmaceuticals incorporated Pediatric Diabetes Therapeutic Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Vertex Pharmaceuticals incorporated Pediatric Diabetes Therapeutic Product Portfolio
6.4.5 Vertex Pharmaceuticals incorporated Recent Developments/Updates
6.5 Novo Nordisk A/S
6.5.1 Novo Nordisk A/S Company Information
6.5.2 Novo Nordisk A/S Description and Business Overview
6.5.3 Novo Nordisk A/S Pediatric Diabetes Therapeutic Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novo Nordisk A/S Pediatric Diabetes Therapeutic Product Portfolio
6.5.5 Novo Nordisk A/S Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Company Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Pediatric Diabetes Therapeutic Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AstraZeneca Pediatric Diabetes Therapeutic Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 MannKind Corporation
6.7.1 MannKind Corporation Company Information
6.7.2 MannKind Corporation Description and Business Overview
6.7.3 MannKind Corporation Pediatric Diabetes Therapeutic Sales, Revenue and Gross Margin (2019-2024)
6.7.4 MannKind Corporation Pediatric Diabetes Therapeutic Product Portfolio
6.7.5 MannKind Corporation Recent Developments/Updates
6.8 Xeris Pharmaceuticals
6.8.1 Xeris Pharmaceuticals Company Information
6.8.2 Xeris Pharmaceuticals Description and Business Overview
6.8.3 Xeris Pharmaceuticals Pediatric Diabetes Therapeutic Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Xeris Pharmaceuticals Pediatric Diabetes Therapeutic Product Portfolio
6.8.5 Xeris Pharmaceuticals Recent Developments/Updates
6.9 Amphastar Pharmaceuticals, Inc.
6.9.1 Amphastar Pharmaceuticals, Inc. Company Information
6.9.2 Amphastar Pharmaceuticals, Inc. Description and Business Overview
6.9.3 Amphastar Pharmaceuticals, Inc. Pediatric Diabetes Therapeutic Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Amphastar Pharmaceuticals, Inc. Pediatric Diabetes Therapeutic Product Portfolio
6.9.5 Amphastar Pharmaceuticals, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pediatric Diabetes Therapeutic Industry Chain Analysis
7.2 Pediatric Diabetes Therapeutic Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pediatric Diabetes Therapeutic Production Mode & Process
7.4 Pediatric Diabetes Therapeutic Sales and Marketing
7.4.1 Pediatric Diabetes Therapeutic Sales Channels
7.4.2 Pediatric Diabetes Therapeutic Distributors
7.5 Pediatric Diabetes Therapeutic Customers
8 Pediatric Diabetes Therapeutic Market Dynamics
8.1 Pediatric Diabetes Therapeutic Industry Trends
8.2 Pediatric Diabetes Therapeutic Market Drivers
8.3 Pediatric Diabetes Therapeutic Market Challenges
8.4 Pediatric Diabetes Therapeutic Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Boehringer Ingelheim International GmbH
Eli Lilly and Company
Sanofi
Vertex Pharmaceuticals Incorporated
Novo Nordisk A S
Astrazeneca plc
MannKind Corporation
Xeris Pharmaceuticals
Amphastar Pharmaceuticals Inc
List of Tables
 Table 1. Global Pediatric Diabetes Therapeutic Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Pediatric Diabetes Therapeutic Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Pediatric Diabetes Therapeutic Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Pediatric Diabetes Therapeutic Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Pediatric Diabetes Therapeutic Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Pediatric Diabetes Therapeutic Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Pediatric Diabetes Therapeutic Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Pediatric Diabetes Therapeutic Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Pediatric Diabetes Therapeutic, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pediatric Diabetes Therapeutic, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pediatric Diabetes Therapeutic, Product Type & Application
 Table 12. Global Key Manufacturers of Pediatric Diabetes Therapeutic, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pediatric Diabetes Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Diabetes Therapeutic as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pediatric Diabetes Therapeutic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Pediatric Diabetes Therapeutic Sales by Region (2019-2024) & (K Units)
 Table 18. Global Pediatric Diabetes Therapeutic Sales Market Share by Region (2019-2024)
 Table 19. Global Pediatric Diabetes Therapeutic Sales by Region (2025-2030) & (K Units)
 Table 20. Global Pediatric Diabetes Therapeutic Sales Market Share by Region (2025-2030)
 Table 21. Global Pediatric Diabetes Therapeutic Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Pediatric Diabetes Therapeutic Revenue Market Share by Region (2019-2024)
 Table 23. Global Pediatric Diabetes Therapeutic Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Pediatric Diabetes Therapeutic Revenue Market Share by Region (2025-2030)
 Table 25. North America Pediatric Diabetes Therapeutic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Pediatric Diabetes Therapeutic Sales by Country (2019-2024) & (K Units)
 Table 27. North America Pediatric Diabetes Therapeutic Sales by Country (2025-2030) & (K Units)
 Table 28. North America Pediatric Diabetes Therapeutic Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Pediatric Diabetes Therapeutic Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Pediatric Diabetes Therapeutic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Pediatric Diabetes Therapeutic Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Pediatric Diabetes Therapeutic Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Pediatric Diabetes Therapeutic Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Pediatric Diabetes Therapeutic Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Pediatric Diabetes Therapeutic Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Pediatric Diabetes Therapeutic Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Pediatric Diabetes Therapeutic Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Pediatric Diabetes Therapeutic Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Pediatric Diabetes Therapeutic Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Pediatric Diabetes Therapeutic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Pediatric Diabetes Therapeutic Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Pediatric Diabetes Therapeutic Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Pediatric Diabetes Therapeutic Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Pediatric Diabetes Therapeutic Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Pediatric Diabetes Therapeutic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Pediatric Diabetes Therapeutic Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Pediatric Diabetes Therapeutic Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Pediatric Diabetes Therapeutic Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Pediatric Diabetes Therapeutic Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Pediatric Diabetes Therapeutic Sales (K Units) by Type (2019-2024)
 Table 51. Global Pediatric Diabetes Therapeutic Sales (K Units) by Type (2025-2030)
 Table 52. Global Pediatric Diabetes Therapeutic Sales Market Share by Type (2019-2024)
 Table 53. Global Pediatric Diabetes Therapeutic Sales Market Share by Type (2025-2030)
 Table 54. Global Pediatric Diabetes Therapeutic Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Pediatric Diabetes Therapeutic Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Pediatric Diabetes Therapeutic Revenue Market Share by Type (2019-2024)
 Table 57. Global Pediatric Diabetes Therapeutic Revenue Market Share by Type (2025-2030)
 Table 58. Global Pediatric Diabetes Therapeutic Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Pediatric Diabetes Therapeutic Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Pediatric Diabetes Therapeutic Sales (K Units) by Application (2019-2024)
 Table 61. Global Pediatric Diabetes Therapeutic Sales (K Units) by Application (2025-2030)
 Table 62. Global Pediatric Diabetes Therapeutic Sales Market Share by Application (2019-2024)
 Table 63. Global Pediatric Diabetes Therapeutic Sales Market Share by Application (2025-2030)
 Table 64. Global Pediatric Diabetes Therapeutic Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Pediatric Diabetes Therapeutic Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Pediatric Diabetes Therapeutic Revenue Market Share by Application (2019-2024)
 Table 67. Global Pediatric Diabetes Therapeutic Revenue Market Share by Application (2025-2030)
 Table 68. Global Pediatric Diabetes Therapeutic Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Pediatric Diabetes Therapeutic Price (US$/Unit) by Application (2025-2030)
 Table 70. Boehringer Ingelheim International GmbH Company Information
 Table 71. Boehringer Ingelheim International GmbH Description and Business Overview
 Table 72. Boehringer Ingelheim International GmbH Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Boehringer Ingelheim International GmbH Pediatric Diabetes Therapeutic Product
 Table 74. Boehringer Ingelheim International GmbH Recent Developments/Updates
 Table 75. Eli Lilly and Company Company Information
 Table 76. Eli Lilly and Company Description and Business Overview
 Table 77. Eli Lilly and Company Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Eli Lilly and Company Pediatric Diabetes Therapeutic Product
 Table 79. Eli Lilly and Company Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Sanofi Pediatric Diabetes Therapeutic Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Vertex Pharmaceuticals incorporated Company Information
 Table 86. Vertex Pharmaceuticals incorporated Description and Business Overview
 Table 87. Vertex Pharmaceuticals incorporated Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Vertex Pharmaceuticals incorporated Pediatric Diabetes Therapeutic Product
 Table 89. Vertex Pharmaceuticals incorporated Recent Developments/Updates
 Table 90. Novo Nordisk A/S Company Information
 Table 91. Novo Nordisk A/S Description and Business Overview
 Table 92. Novo Nordisk A/S Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Novo Nordisk A/S Pediatric Diabetes Therapeutic Product
 Table 94. Novo Nordisk A/S Recent Developments/Updates
 Table 95. AstraZeneca Company Information
 Table 96. AstraZeneca Description and Business Overview
 Table 97. AstraZeneca Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. AstraZeneca Pediatric Diabetes Therapeutic Product
 Table 99. AstraZeneca Recent Developments/Updates
 Table 100. MannKind Corporation Company Information
 Table 101. MannKind Corporation Description and Business Overview
 Table 102. MannKind Corporation Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. MannKind Corporation Pediatric Diabetes Therapeutic Product
 Table 104. MannKind Corporation Recent Developments/Updates
 Table 105. Xeris Pharmaceuticals Company Information
 Table 106. Xeris Pharmaceuticals Description and Business Overview
 Table 107. Xeris Pharmaceuticals Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Xeris Pharmaceuticals Pediatric Diabetes Therapeutic Product
 Table 109. Xeris Pharmaceuticals Recent Developments/Updates
 Table 110. Amphastar Pharmaceuticals, Inc. Company Information
 Table 111. Amphastar Pharmaceuticals, Inc. Description and Business Overview
 Table 112. Amphastar Pharmaceuticals, Inc. Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Amphastar Pharmaceuticals, Inc. Pediatric Diabetes Therapeutic Product
 Table 114. Amphastar Pharmaceuticals, Inc. Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Pediatric Diabetes Therapeutic Distributors List
 Table 118. Pediatric Diabetes Therapeutic Customers List
 Table 119. Pediatric Diabetes Therapeutic Market Trends
 Table 120. Pediatric Diabetes Therapeutic Market Drivers
 Table 121. Pediatric Diabetes Therapeutic Market Challenges
 Table 122. Pediatric Diabetes Therapeutic Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pediatric Diabetes Therapeutic
 Figure 2. Global Pediatric Diabetes Therapeutic Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Pediatric Diabetes Therapeutic Market Share by Type: 2023 & 2030
 Figure 4. Type 1 Product Picture
 Figure 5. Type 2 Product Picture
 Figure 6. Global Pediatric Diabetes Therapeutic Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Pediatric Diabetes Therapeutic Market Share by Application: 2023 & 2030
 Figure 8. Hospitals
 Figure 9. Specialty Clinics
 Figure 10. Others
 Figure 11. Global Pediatric Diabetes Therapeutic Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Pediatric Diabetes Therapeutic Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Pediatric Diabetes Therapeutic Sales (2019-2030) & (K Units)
 Figure 14. Global Pediatric Diabetes Therapeutic Average Price (US$/Unit) & (2019-2030)
 Figure 15. Pediatric Diabetes Therapeutic Report Years Considered
 Figure 16. Pediatric Diabetes Therapeutic Sales Share by Manufacturers in 2023
 Figure 17. Global Pediatric Diabetes Therapeutic Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Pediatric Diabetes Therapeutic Players: Market Share by Revenue in Pediatric Diabetes Therapeutic in 2023
 Figure 19. Pediatric Diabetes Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Pediatric Diabetes Therapeutic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Pediatric Diabetes Therapeutic Sales Market Share by Country (2019-2030)
 Figure 22. North America Pediatric Diabetes Therapeutic Revenue Market Share by Country (2019-2030)
 Figure 23. United States Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Pediatric Diabetes Therapeutic Sales Market Share by Country (2019-2030)
 Figure 26. Europe Pediatric Diabetes Therapeutic Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Pediatric Diabetes Therapeutic Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Pediatric Diabetes Therapeutic Revenue Market Share by Region (2019-2030)
 Figure 34. China Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Pediatric Diabetes Therapeutic Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Pediatric Diabetes Therapeutic Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Pediatric Diabetes Therapeutic Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Pediatric Diabetes Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Pediatric Diabetes Therapeutic by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Pediatric Diabetes Therapeutic by Type (2019-2030)
 Figure 53. Global Pediatric Diabetes Therapeutic Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Pediatric Diabetes Therapeutic by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Pediatric Diabetes Therapeutic by Application (2019-2030)
 Figure 56. Global Pediatric Diabetes Therapeutic Price (US$/Unit) by Application (2019-2030)
 Figure 57. Pediatric Diabetes Therapeutic Value Chain
 Figure 58. Pediatric Diabetes Therapeutic Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Diabetes Mellitus Treatment Market Insights Forecast to 2030
Diabetes Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Type 2 Diabetes Mellitus Treatment Market Research Report 2024
Global Type 1 Diabetes Treatment Market Insights Forecast to 2030
Global Type 2 Diabetes Medicines Market Research Report 2024
Diabetes Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Type 2 Diabetes Medications Market Research Report 2024
Global Diabetes Management Equipment Market Research Report 2024
Global Diabetes Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Oral Antidiabetic OAD Treatment Market Research Report 2024
Diabetes Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetes Pump Therapy Market Research Report 2024
Global Diabetes Therapeutics and Diagnostics Market Insights Forecast to 2030
Global Disposable Diabetes Devices Market Research Report 2024
Type 2 Diabetes Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetic Foot Ulcer Therapeutics Market Research Report 2024
Global Needle Free Diabetes Care Market Research Report 2024
Global Diabetic Foot Ulcer Therapeutic Market Research Report 2024
Injectable Drugs For Type 2 Diabete Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Anti diabetes Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions